Levels of tissue factor pathway inhibitor in lupus patients correlate with lupus activity and endothelial damage markers.
Vanessa Roldán, Pascual Marco, Cristina Fernández, Eliseo Pascual
Abstract
Vanessa Roldán, Pascual Marco, Cristina Fernández, Eliseo Pascual
Abstract
Tissue factor (TF) is a low molecular weight glycoprotein considered a major regulator of coagulation.1 Tissue factor pathway inhibitor (TFPI) appears to play a primary role in regulating TF-induced coagulation, as it is a potent inhibitor of activated factor VII/TF complexes. TFPI is expressed by the endothelium under normal physiologic conditions. The plasma concentration of TFPI is low, and only small amounts circulate in plasma as full-length molecule (free-TFPI).
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Tissue factor (TF) is a low molecular weight glycoprotein considered a major regulator of coagulation.1 Tissue factor pathway inhibitor (TFPI) appears to play a primary role in regulating TF-induced coagulation, as it is a potent inhibitor of activated factor VII/TF complexes. TFPI is expressed by the endothelium under normal physiologic conditions. The plasma concentration of TFPI is low, and only small amounts circulate in plasma as full-length molecule (free-TFPI).
Key concepts: Tissue factor pathway inhibitor, Tissue factor, Coagulation, Thromboplastin, Glycoprotein, Endothelium, Regulator, Systemic lupus erythematosus